Skip to content
Better HN
Top
Best
Ask
Show
New
Jobs
Search
⌘K
0 points
Mirioron
6y ago
0 comments
Save
Share
Well, it depends on what citizenship you have. The point is that if it's expensive in the US now then perhaps in the future it will be cheaper and available elsewhere.
0 comments
1 comments · 1 top-level
top
newest
oldest
claudeganon
6y ago
The purchasing and marking up of expired drugs/patents and blocking of transition to generic status seem the obvious counterexamples here...
https://hbr.org/2017/04/how-pharma-companies-game-the-system...
j
/
k
navigate · click thread line to collapse